Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 3Phase 2 2Phase EARLY_PHASE1 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 16Plasma cell 11Other hematologic neoplasm 9Gastrointestinal 4CNS 4Sarcoma 3Dermatologic 3Myeloid 2Genitourinary 2Endocrine 2Breast 2Thoracic 1NET 1Head & Neck 1

Conditions

Breast Neoplasms 2

Interventions

Trastuzumab 349Paclitaxel 310Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 215Letrozole 185Fulvestrant 178Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 114pembrolizumab 113Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 66Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Panobinostat × Breast × Clear all
NCT00777049 2016-07-15

Study of Panobinostat Monotherapy in Women With HER2-negative Locally Recurrent or Metastatic Breast Cancer

Translational Research in Oncology

Phase 2 Completed
54 enrolled 12 charts
Breast

Breast Neoplasms

NCT00777335 2015-11-24

Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer

Translational Research in Oncology

Phase 2 Terminated
4 enrolled 11 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡